Journal Home > Volume 2 , Issue 1
Background

Global evidence on the transmission of asymptomatic SARS-CoV-2 infection needs to be synthesized.

Methods

A search of 4 electronic databases (PubMed, EMBASE, Cochrane Library, and Web of Science databases) as of January 24, 2021 was performed. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed. Studies which reported the transmission rate among close contacts with asymptomatic SARS-CoV-2 cases were included, and transmission activities occurred were considered. The transmission rates were pooled by zero-inflated beta distribution. The risk ratios (RRs) were calculated using random-effects models.

Results

Of 4923 records retrieved and reviewed, 15 studies including 3917 close contacts with asymptomatic indexes were eligible. The pooled transmission rates were 1.79 per 100 person-days (or 1.79%, 95% confidence interval [CI] 0.41%–3.16%) by asymptomatic index, which is significantly lower than by presymptomatic (5.02%, 95% CI 2.37%–7.66%; p < 0.001), and by symptomatic (5.27%, 95% CI 2.40%–8.15%; p < 0.001). Subgroup analyses showed that the household transmission rate of asymptomatic index was (4.22%, 95% CI 0.91%–7.52%), four times significantly higher than non-household transmission (1.03%, 95% CI 0.73%–1.33%; p=0.03), and the asymptomatic transmission rate in China (1.82%, 95% CI 0.11%–3.53%) was lower than in other countries (2.22%, 95% CI 0.67%–3.77%; p=0.01).

Conclusions

People with asymptomatic SARS-CoV-2 infection are at risk of transmitting the virus to their close contacts, particularly in household settings. The transmission potential of asymptomatic infection is lower than symptomatic and presymptomatic infections. This meta-analysis provides evidence for predicting the epidemic trend and promulgating vaccination and other control measures. Registered with PROSPERO International Prospective Register of Systematic Reviews, CRD42021269446; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=269446.


menu
Abstract
Full text
Outline
About this article

Transmission risk of asymptomatic SARS-CoV-2 infection: a systematic review and meta-analysis

Show Author's information Ci Zhangab1Chao Zhouc1Wanqing XudShimin ZhengeYanxiao GaofPeiqi LigLuojia DengcXuezhixing ZhanghQianxue JiangcFrank QianiXianhong LiabHonghong WangabHuachun ZoufYinglin XiajTao WangcHui LucHan-Zhu Qianh#( )
Xiangya School of Nursing, Central South University, Changsha, China
Xiangya Center for Evidence-Based Nursing Practice & Healthcare Innovation (A JBI Affiliated Group), Changsha, Hunan Province, China
Department of Bioinformatics and Biostatistics, Shanghai Jiao Tong University, Shanghai, China
T.H. Chan School of Public Health, Harvard University, Boston, MA, USA
Department of Biostatistics and Epidemiology, East Tennessee State University, Johnson City, TN, USA
School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China
School of Acupuncture-Moxibustion and Tuina, Shanghai University of Traditional Chinese Medicine, Shanghai, China
School of Public Health, Yale University, New Haven, CT, USA
Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA

1 These authors contributed equally to this work.

Abstract

Background

Global evidence on the transmission of asymptomatic SARS-CoV-2 infection needs to be synthesized.

Methods

A search of 4 electronic databases (PubMed, EMBASE, Cochrane Library, and Web of Science databases) as of January 24, 2021 was performed. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed. Studies which reported the transmission rate among close contacts with asymptomatic SARS-CoV-2 cases were included, and transmission activities occurred were considered. The transmission rates were pooled by zero-inflated beta distribution. The risk ratios (RRs) were calculated using random-effects models.

Results

Of 4923 records retrieved and reviewed, 15 studies including 3917 close contacts with asymptomatic indexes were eligible. The pooled transmission rates were 1.79 per 100 person-days (or 1.79%, 95% confidence interval [CI] 0.41%–3.16%) by asymptomatic index, which is significantly lower than by presymptomatic (5.02%, 95% CI 2.37%–7.66%; p < 0.001), and by symptomatic (5.27%, 95% CI 2.40%–8.15%; p < 0.001). Subgroup analyses showed that the household transmission rate of asymptomatic index was (4.22%, 95% CI 0.91%–7.52%), four times significantly higher than non-household transmission (1.03%, 95% CI 0.73%–1.33%; p=0.03), and the asymptomatic transmission rate in China (1.82%, 95% CI 0.11%–3.53%) was lower than in other countries (2.22%, 95% CI 0.67%–3.77%; p=0.01).

Conclusions

People with asymptomatic SARS-CoV-2 infection are at risk of transmitting the virus to their close contacts, particularly in household settings. The transmission potential of asymptomatic infection is lower than symptomatic and presymptomatic infections. This meta-analysis provides evidence for predicting the epidemic trend and promulgating vaccination and other control measures. Registered with PROSPERO International Prospective Register of Systematic Reviews, CRD42021269446; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=269446.

Keywords: Meta-analysis, Systematic review, SARS-CoV-2, Asymptomatic, Transmission rate

References(43)

[1]

D. Buitrago-Garcia, D. Egli-Gany, M.J. Counotte, et al., Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis, PLoS Med 17 (9) (2020) e1003346.

[2]

M. Yanes-Lane, N. Winters, F. Fregonese, et al., Proportion of asymptomatic infection among COVID-19 positive persons and their transmission potential: A systematic review and meta-analysis, PLoS One 15 (11) (2020) e0241536.

[3]

J. He, Y. Guo, R. Mao, et al., Proportion of asymptomatic coronavirus disease 2019: a systematic review and meta-analysis, J Med Virol 93 (2) (2021) 820–830.

[4]

M. Lipsitch, D.L. Swerdlow, L. Finelli, Defining the epidemiology of covid-19 - studies needed, N Engl J Med 382 (13) (2020) 1194–1196.

[5]
C. Savvides, R. Siegel. Asymptomatic and presymptomatic transmission of SARSCoV-2: A systematic review. medRxiv. 2020.
DOI
[6]

W.C. Koh, L. Naing, L. Chaw, et al., What do we know about SARS-CoV-2 transmission? A systematic review and meta-analysis of the secondary attack rate and associated risk factors, PLoS One 15 (10) (2020) e0240205.

[7]

Z.J. Madewell, Y. Yang, I.M. Longini Jr., et al., Household transmission of SARS–CoV-2: a systematic review and meta-analysis, JAMA Netw Open 3 (12) (2020) e2031756.

[8]

K. Ravindra, V.S. Malik, B.K. Padhi, et al., Asymptomatic infection and transmission of COVID-19 among clusters: systematic review and meta-analysis, Public Health 203 (2022) 100–109.

[9]

D. Moher, A. Liberati, J. Tetzlaff, et al., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Med 6 (7) (2009) e1000097.

[10]

Y. Bai, L. Yao, T. Wei, et al., Presumed Asymptomatic Carrier Transmission of COVID-19, JAMA 323 (14) (2020) 1406–1407.

[11]

Z. Hu, C. Song, C. Xu, et al., Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China, Sci China Life Sci 63 (5) (2020) 706–711.

[12]

R. Kant, K. Zaman, P. Shankar, et al., A preliminary study on contact tracing & transmission chain in a cluster of 17 cases of severe acute respiratory syndrome coronavirus 2 infection in Basti, Uttar Pradesh, India, Indian J Med Res 152 (1 & 2) (2020) 95–99.

[13]

J. Liu, J. Huang, D. Xiang, Large SARS-CoV-2 outbreak caused by asymptomatic traveler, China, Emerg Infect Dis 26 (9) (2020) 2260–2263.

[14]

N. Charlotte, High Rate of SARS-CoV-2 transmission due to choir practice in france at the beginning of the COVID-19 pandemic, J Voice (2020) https://doi.org/10.1016/j.jvoice.2020.11.029.

[15]

M.M. Plucinski, M. Wallace, A. Uehara, et al., Coronavirus Disease 2019 (COVID-19) in Americans aboard the diamond princess cruise ship, Clin Infect Dis 72 (10) (2021) e448–ee57.

[16]

Z. Munn, S. Moola, K. Lisy, et al., Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data, Int J Evid Based Healthc 13 (3) (2015) 147–153.

[17]

Y.K. Fang Liu, zoib: An R Package for Bayesian Inference for Beta Regression and Zero/One Inflated Beta Regression, R J (2015) 7/2.

[18]

J.J. Barendregt, S.A. Doi, Y.Y. Lee, et al., Vos T. Meta-analysis of prevalence, J Epidemiol Community Health 67 (11) (2013) 974–978.

[19]

V.N. Nyaga, M. Arbyn, M. Aerts, Metaprop: a stata command to perform meta-analysis of binomial data, Arch Public Health 72 (1) (2014) 39.

[20]

M.J. Sweeting, A.J. Sutton, P.C. Lambert, What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data, Stat Med 23 (9) (2004) 1351–1375.

[21]

S. Cao, Y. Gan, C. Wang, et al., Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China, Nat Commun 11 (1) (2020) 5917.

[22]

L.L. Blaisdell, W. Cohn, J.R. Pavell, et al., Preventing and mitigating SARS-CoV-2 Transmission - four overnight camps, maine, June-August 2020, MMWR Morb Mortal Wkly Rep 69 (35) (2020) 1216–1220.

[23]

L. Chaw, W.C. Koh, S.A. Jamaludin, et al., Analysis of SARS-CoV-2 transmission in different settings, Brunei. Emerg Infect Dis 26 (11) (2020) 2598–2606.

[24]

G. Yin, H. Jin, Comparison of transmissibility of coronavirus between symptomatic and asymptomatic patients: reanalysis of the ningbo COVID-19 data, JMIR Public Health Surveill 6 (2) (2020) e19464.

[25]

M. Gao, L. Yang, X. Chen, et al., A study on infectivity of asymptomatic SARS-CoV-2 carriers, Respir Med 169 (2020) 106026.

[26]

N. Gupta, K. Saravu, M. Varma, et al., Transmission of SARS-CoV-2 infection by children: a study of contacts of index paediatric cases in India, J Trop Pediatr 67 (1) (2021).

[27]

T. Han, Outbreak investigation: transmission of COVID-19 started from a spa facility in a local community in Korea, Epidemiol Health 42 (2020) e2020056.

[28]

X. Han, X. Wei, O. Alwalid, et al., Severe acute respiratory syndrome coronavirus 2 among asymptomatic workers screened for work resumption, China. Emerg Infect Dis 26 (9) (2020) 2265–2267.

[29]

X.L. Jiang, X.L. Zhang, X.N. Zhao, et al., Transmission potential of asymptomatic and paucisymptomatic severe acute respiratory syndrome coronavirus 2 infections: a 3-family cluster study in China, J Infect Dis 221 (12) (2020) 1948–1952.

[30]

H.Y. Cheng, S.W. Jian, D.P. Liu, et al., Contact tracing assessment of COVID-19 transmission dynamics in taiwan and risk at different exposure periods before and after symptom onset, JAMA Intern Med 180 (9) (2020) 1156–1163.

[31]

Z. Liu, R. Chu, L. Gong, et al., The assessment of transmission efficiency and latent infection period in asymptomatic carriers of SARS-CoV-2 infection, Int J Infect Dis 99 (2020) 325–327.

[32]

L. Luo, D. Liu, X. Liao, et al., Contact settings and risk for transmission in 3410 close contacts of patients with COVID-19 in Guangzhou, China: a prospective cohort study, Ann Intern Med 173 (11) (2020) 879–887.

[33]

Q. Shi, Y. Hu, B. Peng, et al., Effective control of SARS-CoV-2 transmission in Wanzhou, China, Nat Med 27 (1) (2021) 86–93.

[34]

S.Y. Park, Y.M. Kim, S. Yi, et al., Coronavirus disease outbreak in call center, South Korea, Emerg Infect Dis 26 (8) (2020) 1666–1670.

[35]

W. Zhang, W. Cheng, L. Luo, et al., Secondary transmission of coronavirus disease from presymptomatic persons, China, Emerg Infect Dis 26 (8) (2020) 1924–1926.

[36]
World Health Organization. Transmission of SARS-CoV-2: implications for infection prevention precautions 2020. https://www.who.int/news-room/commentaries/detail/transmission-of-sars-cov-2-implications-for-infection-prevention-precautions.
[37]

C. Rhee, S. Kanjilal, M. Baker, et al., Duration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity: when is it safe to discontinue isolation? Clin Infect Dis 72 (8) (2021) 1467–1474.

[38]

O.T. Ng, K. Marimuthu, V. Koh, et al., SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study, Lancet Infect Dis 21 (3) (2021) 333–343.

[39]

Y. Liu, J. Rocklöv, The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus, J Travel Med 28 (7) (2021) taab124.

[40]
M. Cascella, M. Rajnik, A. Aleem, et al., Evaluation, and Treatment of Coronavirus (COVID-19), StatPearls, Treasure Island FL, 2021 © 2021, StatPearls Publishing LLC. .
[41]
World Health Organization. Tracking SARS-CoV-2 variants 2022. https://www.who.int/activities/tracking-SARS-CoV-2-variants.
[42]

L. Obress, O. Berke, D.N. Fisman, et al., Sporadic SARS-CoV-2 cases at the neighbourhood level in Toronto, Ontario, 2020: a spatial analysis of the early pandemic period, CMAJ Open 10 (1) (2022) E190–E1e5.

[43]

V.C. Cheng, S.C. Wong, V.W. Chuang, et al., The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2, J Infect 81 (1) (2020) 107–114.

Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Received: 05 October 2022
Revised: 24 November 2022
Accepted: 03 December 2022
Published: 17 December 2022
Issue date: March 2023

Copyright

© 2022 The Author(s). Published by Elsevier Ltd on behalf of Tsinghua University Press.

Acknowledgements

Acknowledgements

Not applicable.

Rights and permissions

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Return